Evaluation of the introduction of ORTHO VISION<sup>®</sup>

DOI
  • NAKAJIMA Atsuko
    Transfusion Department, Dokkyo Medical University Saitama Medical Center
  • SUGITA Konomi
    Transfusion Department, Dokkyo Medical University Saitama Medical Center
  • KUDOU Sayaka
    Transfusion Department, Dokkyo Medical University Saitama Medical Center
  • ISHIKAWA Takanori
    Transfusion Department, Dokkyo Medical University Saitama Medical Center
  • HONDA Natsue
    Clinical Laboratory Department, Dokkyo Medical University Saitama Medical Center
  • TOU Masako
    Clinical Laboratory Department, Dokkyo Medical University Saitama Medical Center
  • HARUKI Kousuke
    Clinical Laboratory Department, Dokkyo Medical University Saitama Medical Center
  • HIGUCHI Takakazu
    Transfusion Department, Dokkyo Medical University Saitama Medical Center

Bibliographic Information

Other Title
  • オーソビジョンの機能性評価

Search this article

Abstract

<p>Nowadays, it is necessary that a hospital transfusion unit provides 24-hr laboratory service. Automated immunohematology analyzers with high performance and novel transfusion management systems are being continuously developed for standardization and better quality control of immunohematology tests and for efficient laboratory work. To introduce an automated analyzer, its performance and the conditions of the hospital, such as laboratory personnel and introductory and running costs, must be considered. We have been providing a 24-hr immunohematology service by medical technologists since the opening of our hospital in 1984. Afterward, a transfusion management system and AutoVue® were introduced, and immunohematological tests outside hospital hours were completely automated. Electronic medical records were introduced later. The AutoVue® Innova system was upgraded to ORTHO VISION® in 2016. Two analyzers were introduced and a back-up system was established in case of problems. A questionnaire survey revealed that the burden of the technologists in the laboratory was greatly reduced with the introduction of ORTHO VISION®. Consumptions of IgG cassettes and reagent red blood cells were reduced by 8–10%. We judged that the performance and operability of ORTHO VISION® were suitable for our hospital.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top